5-溴-2-碘-3-甲氧基吡啶 | 944805-60-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 5-溴-2-碘-3-甲氧基吡啶
• 中文别名: 2-溴-3-碘-5-甲氧基-吡啶
• 英文名称: 5-bromo-2-iodo-3-methoxy-pyridine
• 英文别名: 5-Bromo-2-iodo-3-methoxypyridine
• CAS: 944805-60-1
• 化学式: C₆H₅BrINO
• 分子量: 313.92
• InChiKey: JHZQBZOJQDBRHT-UHFFFAOYSA-N

物化性质

• 熔点：
  76-78°C
• 沸点：
  298.6±40.0 °C(Predicted)
• 密度：
  2.166±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  22.1
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• WGK Germany：
  3
• 危险标志：
  GHS07
• 危险性描述：
  H315,H319,H335
• 危险性防范说明：
  P280,P304 + P340 + P312,P305 + P351 + P338,P337 + P313

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Bromo-2-iodo-3-methoxypyridine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Bromo-2-iodo-3-methoxypyridine
CAS number: 944805-60-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H5BrINO
Molecular weight: 313.9

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-溴-2-碘-3-甲氧基吡啶 在 manganese(IV) oxide 、 异丙基氯化镁 、 palladium diacetate 、 caesium carbonate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 、 lithium chloride 、 lithium hydroxide 作用下， 以 四氢呋喃 、 水 、 甲苯 为溶剂， 反应 51.5h， 生成 2-(3-methoxy-5-{propyl[3-(trifluoromethyl)phenyl]amino}pyridine-2-carbonyl)cyclopropane-1-carboxylic acid
  参考文献：
  名称：

  口服白三烯C4合酶抑制剂（1S，2S）-2-（{5-[（5-氯-2,4-二氟苯基）（2-氟-2-甲基丙基）氨基] -3-甲氧基吡嗪-2-的发现芳基}羰基）环丙烷甲酸（AZD9898）作为治疗哮喘的新方法。

  摘要：

  虽然支气管扩张药和吸入性糖皮质激素是哮喘治疗的主要手段，但高达50％的哮喘患者仍未得到控制。许多研究表明，半胱氨酸白三烯级联反应在某些哮喘患者中仍保持高度活化，即使是在大剂量吸入或口服皮质类固醇药物中也是如此。因此，对白三烯C4合酶（LTC4S）酶的抑制作用可为高度激活的半胱氨酰白三烯级联反应的患者提供一种新的，差异化的核心治疗方法。从筛选命中（3）开始，发现LTC4S口服抑制剂的程序导致了（1S，2S）-2-（{5-[（5-chloro-2,4-difluorophenyl）（2-fluoro-2-甲基丙基）氨基] -3-甲氧基吡嗪-2-基}羰基）环丙烷甲酸（AZD9898）（36），具有高亲脂性配体效率（LLE = 8.5）的皮摩尔LTC4S抑制剂（IC50 = 0.28 nM），口服给药后，在钙离子载体刺激的大鼠模型中，其在细胞（外周血单核细胞，IC50，游离= 6.2 nM）中表现

  DOI：

  10.1021/acs.jmedchem.9b00555
• 作为产物：
  描述：

  5-溴-2-氯-3-甲氧基吡啶 在 三甲基氯硅烷 、 sodium iodide 作用下， 以 乙腈 为溶剂， 反应 12.0h， 生成 5-溴-2-碘-3-甲氧基吡啶
  参考文献：
  名称：

  WO2021062316A5

  摘要：

  公开号：

  WO2021062316A5

文献信息

• Thiazole compounds and methods of use
  申请人：Zeng Qingping

  公开号：US20070173506A1

  公开（公告）日：2007-07-26

  The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.

  该发明涉及Formula I和Formula II的噻唑化合物及其组合物，用于治疗由蛋白激酶B（PKB）介导的疾病，其中变量具有此处提供的定义。该发明还涉及这种噻唑化合物及其组合物在治疗与异常细胞生长、癌症、炎症和代谢紊乱相关的疾病状态中的治疗用途。
• 一种RET激酶抑制剂中间体及其制备方法
  申请人：厦门云凡医药科技有限公司

  公开号：CN113816955B

  公开（公告）日：2022-08-26

  一种RET激酶抑制剂中间体及其制备方法，涉及药物化学领域，所述RET激酶抑制剂中间体的结果如式(7)所示，所述制备方法其包括：步骤1)化合物5与卤代丙烯腈在有机碱和氧化剂中进行反应，得到化合物6；步骤2)化合物在质子溶剂中，在还原剂存在下进行还原反应获得化合物7。
• [EN] NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF<br/>[FR] NOUVEAUX MODULATEURS DU RÉCEPTEUR D'HYDROCARBURE ARYLE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：ALLIANTHERA SUZHOU BIOPHARMACEUTICAL CO LTD

  公开号：WO2023086428A3

  公开（公告）日：2023-08-03
• EP1981884A2
  申请人：——

  公开号：EP1981884A2

  公开（公告）日：2008-10-22
• THIAZOLE COMPOUNDS AS PROTEIN KINASE B (PKB) INHIBITORS
  申请人：Amgen, Inc

  公开号：EP1981884B1

  公开（公告）日：2012-06-13